Similarly, the downregulation of ABCB1 expression in cancer cells is associated with a reduction in H3/H4ac, and changes in ABCB1 expression and/or activity can be observed with the use of HDAC inhibitors (You et al., 2020; Ni et al., 2015). This evidence concerns the gene ABCB1 and cancer.